TE_8678
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L2a_3end |
---|---|
TE superfamily | L2 |
TE class | LINE |
Gene | RAB43, ISY1-RAB43 |
Class | Chimeric |
Coding | Non-coding |
Tumor-specific score | 0.05 |
Counts of samples | TCGA_tumor:109; TCGA_normal:31; GTEx:2579 |
TSS | chr3(-):129101394 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_8678.1 | RAB43, ISY1-RAB43 | Chimeric | Non-coding | Non-coding | chr3(-):129091326,129091346,129094986,129095169,129101315,129101395 |
teRNA_8678.2 | RAB43, ISY1-RAB43 | Chimeric | Non-coding | Non-coding | chr3(-):129091326,129091346,129092500,129092593,129094986,129095169,129101315,129101395 |
teRNA_8678.3 | RAB43, ISY1-RAB43 | Chimeric | Non-coding | Non-coding | chr3(-):129092573,129092593,129094986,129095169,129101315,129101395 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.